FeesSafety
Pluang+

Dr. Patrick Nunally to speak on AI and humanity at Vatican event inspired by Pope Leo XIV's encyclical.

Market News
29 Oct 2026, 13:00 WIB
PRNewsWire
View Source
Bullish
Dr. Patrick Nunally to speak on AI and humanity at Vatican event inspired by Pope Leo XIV's encyclical.

Dr. Patrick Nunally, Co-Founder and Chief Scientist of Brand Engagement Network, will speak at a Vatican City discussion on Nov. 20, 2026, about artificial intelligence and its impact on humanity, inspired by Pope Leo XIV's encyclical Magnifica Humanitas. The event gathers AI pioneers and thinkers to explore the intersection of faith, technology, and ethical AI use. Nunally's extensive AI patents and decades of research emphasize the importance of maintaining human accountability in AI development. This highlights BEN's leadership in creating AI that understands human intent and behavior while ensuring ethical oversight.

Brand Engagement Network Co-Founder Dr. Patrick Nunally's invitation to speak at the Vatican on AI and the human spirit provides context for technology sector interest. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 29, 2026 15:51 WIB: out of 150 priced US tech stocks, 25 rose and 122 fell. Notable movers include OKTA at USD 211.11 with 0% sell and 100% buy order activity, CRWD at USD 253.00 with 74% sell and 26% buy, and FRSH at USD 14.65 with 100% sell and 0% buy activity.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
15 minutes ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
15 minutes ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
1 hour ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
1 hour ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App